Evasc Neurovascular
PrivateLast Round
Grant
Feb 23, 2021
Total Funding Raised
$10.84M
Company Overview
Evasc Neurovascular is a medical device company that develops endovascular treatment systems for cerebral aneurysms.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Evasc Neurovascular Comparables
Compare Evasc Neurovascular with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Acandis | 89% | |
| Wallaby Medical | 82% | |
| Terumo Corporation | 79% | |
Evasc Neurovascular Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 23, 2021 | ||||
| Series A | Jun 15, 2017 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 22, 2026
Monthly visitors increased 90% MoM.
- May 2, 2025
Monthly visitors increased 141% MoM, reaching 1.4K.
Evasc Neurovascular Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Evasc Neurovascular's valuation, stock price, and market status.